Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin

NCT00906529 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Levemir (Detemir) and Novolog (Aspart) Insulin

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]